Related Experiment Video
Updated: Mar 21, 2026

10:41
A Tuberculosis Molecular Bacterial Load Assay TB-MBLA
Published on: April 30, 2020
14.9K
Tuberculosis infection tests for contact screening in Brazil: a cost-effectiveness analysis
Fernanda Souza1, Ricardo Steffen2, Marcia Pinto3
1Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
Lancet Regional Health. Americas
|March 20, 2026
Summary
The new tuberculosis (TB) antigen-based skin tests (TBST) are cost-saving for diagnosing TB infection in household contacts in Brazil. These TBST offer a more specific and affordable alternative to existing methods.
Area of Science:
- Public Health
- Infectious Disease Diagnostics
- Health Economics
Background:
- WHO recommends three new tuberculosis antigen-based skin tests (TBST) for tuberculosis infection diagnosis.
- Household contacts (HHC) of individuals with pulmonary TB face elevated TBI risk.
- This study assesses the cost-effectiveness of TBST and QFT-Plus® versus TST in Brazil.
Purpose of the Study:
- To evaluate the cost-effectiveness of new TBST and QFT-Plus® compared to TST for diagnosing TB infection in household contacts in Brazil.
- To determine the most cost-saving diagnostic strategy within the Brazilian public health system.
Main Methods:
- A state-transition Markov model simulated four age cohorts of HIV-negative HHC over five years.
- Effectiveness data were sourced from systematic reviews; costs were obtained from Brazilian government and manufacturers.
- Incremental cost-effectiveness analysis was performed to calculate the cost per TB case averted.
Main Results:
- TBST demonstrated similar accuracy to QFT-Plus® and superior specificity compared to TST.
- TBST were less costly than TST and QFT-Plus®.
- All TBST were found to be cost-saving across all age groups, with Cy-Tb® being the most cost-saving.
Conclusions:
- Implementing new TBST for screening HHC in Brazil's public health system presents a cost-saving strategy.
- The existing infrastructure and workforce skills for TST allow for straightforward adoption of TBST.
Related Concept Videos
Pulmonary Tuberculosis IV
623
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
623
Pulmonary Tuberculosis V
746
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
746
Pulmonary Tuberculosis I
1.2K
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.2K
Pulmonary Tuberculosis II
1.9K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.9K
Pulmonary Tuberculosis III
1.3K
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
1.3K

